Ignatius Thomas

2.8k total citations · 1 hit paper
12 papers, 2.0k citations indexed

About

Ignatius Thomas is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Ignatius Thomas has authored 12 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Nephrology. Recurrent topics in Ignatius Thomas's work include Heart Failure Treatment and Management (8 papers), Adenosine and Purinergic Signaling (2 papers) and Cardiac pacing and defibrillation studies (2 papers). Ignatius Thomas is often cited by papers focused on Heart Failure Treatment and Management (8 papers), Adenosine and Purinergic Signaling (2 papers) and Cardiac pacing and defibrillation studies (2 papers). Ignatius Thomas collaborates with scholars based in United States, United Kingdom and Australia. Ignatius Thomas's co-authors include Prakash Deedwania, Bertram Pitt, Felipe A Martinez, Duane Snavely, Paul Chang, Robert Segal, Alan Cowley, Edward P. Havranek, Marvin A. Konstam and James E. Udelson and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Ignatius Thomas

12 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1997 1.2k citations Bertram Pitt, Robert Segal et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ignatius Thomas United States	9	1.6k	555	332	285	154	12	2.0k
Jay M. Sullivan United States	23	1.5k 0.9×	242 0.4×	822 2.5×	159 0.6×	70 0.5×	72	2.8k
Masayoshi Oikawa Japan	27	1.3k 0.8×	389 0.7×	164 0.5×	597 2.1×	135 0.9×	144	2.3k
Hisashi Yokoshiki Japan	27	2.0k 1.2×	213 0.4×	110 0.3×	695 2.4×	105 0.7×	96	2.7k
B. Jackson Australia	21	664 0.4×	312 0.6×	275 0.8×	279 1.0×	328 2.1×	57	1.5k
Bernhard M. Kaess Germany	20	1.3k 0.8×	204 0.4×	200 0.6×	283 1.0×	111 0.7×	62	2.1k
Dinko Sušić United States	30	1.4k 0.9×	209 0.4×	576 1.7×	328 1.2×	167 1.1×	91	2.2k
Philip C. Kirlin United States	17	1.9k 1.2×	422 0.8×	264 0.8×	251 0.9×	72 0.5×	32	2.4k
Nigel Wheeldon United Kingdom	18	1.1k 0.7×	202 0.4×	370 1.1×	142 0.5×	233 1.5×	40	1.6k
Heinrich Brunner Switzerland	20	1.0k 0.6×	242 0.4×	389 1.2×	385 1.4×	110 0.7×	51	1.6k
G Hendrix United States	10	2.0k 1.3×	453 0.8×	95 0.3×	484 1.7×	45 0.3×	22	2.6k

Countries citing papers authored by Ignatius Thomas

Since Specialization

Citations

This map shows the geographic impact of Ignatius Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignatius Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignatius Thomas more than expected).

Fields of papers citing papers by Ignatius Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignatius Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignatius Thomas. The network helps show where Ignatius Thomas may publish in the future.

Co-authorship network of co-authors of Ignatius Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Ignatius Thomas. A scholar is included among the top collaborators of Ignatius Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignatius Thomas. Ignatius Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Udelson, James E., Martin Bilsker, Paul J. Hauptman, et al.. (2011). A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Tolvaptan Monotherapy Compared to Furosemide and the Combination of Tolvaptan and Furosemide in Patients With Heart Failure and Systolic Dysfunction. Journal of Cardiac Failure. 17(12). 973–981. 71 indexed citations

Gottlieb, Stephen S., Barry Ticho, Aaron Deykin, et al.. (2010). Effects of BG9928, an Adenosine A₁Receptor Antagonist, in Patients With Congestive Heart Failure. The Journal of Clinical Pharmacology. 51(6). 899–907. 12 indexed citations

Greenberg, Barry, Ignatius Thomas, Steven Goldman, et al.. (2007). Effects of Multiple Oral Doses of an A1Adenosine Antagonist, BG9928, in Patients With Heart Failure. Journal of the American College of Cardiology. 50(7). 600–606. 53 indexed citations

Hughes, Andrew, et al.. (2002). Assessment of the reproducibility of intradermal administration of capsaicin as a model for inducing human pain. Pain. 99(1). 323–331. 49 indexed citations

Gottlieb, Stephen S., D. Craig Brater, Ignatius Thomas, et al.. (2002). BG9719 (CVT-124), an A ₁ Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy. Circulation. 105(11). 1348–1353. 278 indexed citations

Klapholz, Marc, Ignatius Thomas, Calvin Eng, et al.. (2001). Effects of omapatrilat on hemodynamics and safety in patients with heart failure. The American Journal of Cardiology. 88(6). 657–661. 10 indexed citations

Udelson, James E., William Smith, G Hendrix, et al.. (2001). Acute Hemodynamic Effects of Conivaptan, a Dual V _1A and V ₂ Vasopressin Receptor Antagonist, in Patients With Advanced Heart Failure. Circulation. 104(20). 2417–2423. 266 indexed citations

Havranek, Edward P., Ignatius Thomas, William Smith, et al.. (1999). Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure. Journal of the American College of Cardiology. 33(5). 1174–1181. 49 indexed citations

Thomas, Ignatius, et al.. (1998). The Effects of Danazol After Endometrial Resection: Results of a randomized, placebo‐controlled, double‐blind study. Australian and New Zealand Journal of Obstetrics and Gynaecology. 38(2). 210–214. 3 indexed citations

10.

Klapholz, Marc, Ignatius Thomas, Calvin Eng, et al.. (1998). Omapatrilat, a novel cardiovascular agent, improves hemodynamics in patients with heart failure. Journal of Cardiac Failure. 4(3). 41–41. 4 indexed citations

11.

Pitt, Bertram, Robert Segal, Felipe A Martinez, et al.. (1997). Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). The Lancet. 349(9054). 747–752. 1207 indexed citations breakdown →

12.

Mautner, Richard K., Ignatius Thomas, Raja W. Dhurandhar, & John H. Phillips. (1979). Hypertrophic Obstructive Cardiomyopathy and Coronary Artery Spasm. CHEST Journal. 76(6). 636–639. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact